Modification of human MSC surface with oligopeptide-PEG-lipids for selective binding to activated endothelium
Modification of human MSC surface with oligopeptide-PEG-lipids for selective binding to activated endothelium
复制标题
用寡肽-PEG-脂质修饰人 MSC 表面以选择性结合活化的内皮细胞
DOI:
10.1002/jbm.a.36697
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
and Yuji Teramura
中科院分区:
文献类型:
--
作者:
Makoto Noiri;Kenta Asawa;Naoya Okada1;Tomonobu Kodama;Yuichi Murayama;Yuuki Inoue;Kazuhiko Ishihara;Kristina N Ekdahl;Bo Nilsson;and Yuji Teramura
Promising cell therapies using mesenchymal stem cells (MSCs) is proposed for stroke patients. Therefore, we aimed to efficiently accumulate human MSC (hMSC) to damaged brain area to improve the therapeutic effect using poly(ethylene glycol) (PEG)‐conjugated phospholipid (PEG‐lipid) carrying an oligopeptide as a ligand, specific for E‐selectin which is upregulated on activated endothelial cells under hypoxia‐like stroke. Here we synthesized E‐selectin‐binding oligopeptide (ES‐bp) conjugated with PEG spacer having different molecular weights from 1 to 40 kDa. We found that ES‐bp can be immobilized onto the hMSC surface through PEG‐lipid without influence on cell growth and differentiation into adipocytes and osteocytes, respectively. It is also possible to control the immobilization of ES‐bp on hMSC surface (<108ES‐bp per cell). Immobilized ES‐bp can be continuously immobilized at the outside of cell membrane when PEG‐lipids with PEG 5 and 40 kDa were used. In addition, the modified hMSC can specifically attach onto E‐selectin‐immobilized surface as a model surface of activated endothelium in human blood, indicating the sufficient number of immobilized ES‐bp onto hMSC. Thus, this technique is one of the candidates for hMSC accumulation to cerebral infarction area. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 1779–1792, 2019.